Casandra
Casandra Test Code QD15070Version 1 (DRAFT)
Performing Lab
MELANOMASEQ
Clinical Use
Order TestUse
Disease‑specific solid tumor panel intended to aid the oncologist in prioritizing standard of care therapy and clinical trial choices for patients with advanced stage melanoma.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
NGS (Targeted)
Biomarkers
BRAF, NRAS, KIT
GeneSNV/Indel
Mutation • Categorical (e.g., Positive / Negative / Indeterminate)
Result Turnaround Time
8-10 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Tissue
Volume
Not provided
Minimum Volume
Not provided
Container
Paraffin‑embedded tissue block
Collection Instructions
Formalin‑fixed paraffin‑embedded block OR Core Needle Biopsy (4‑6 aspirates, 18 gauge needle preferred) OR Fine Needle Aspirate OR Malignant fluid in formalin‑fixed paraffin‑embedded block
Storage Instructions
Room temperature and Refrigerated Indefinitely; Frozen Unacceptable
Causes for Rejection
Decalcified tissue specimen
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Indefinitely |
| Refrigerated | Indefinitely |
| Frozen | Unacceptable |
Similar Tests
Other tests from different labs that may be relevant
NeoTYPE Melanoma Profile
NeoGenomics
BRAF and KIT Mutation Analysis, Next-Generation Sequencing, Tumor
Mayo Clinic Lab
Melanoma Panel
Prevention Genetics
BRAF Gene Mutation Analysis - Melanoma
Labcorp
KIT Mutations Melanoma
ARUP Laboratories
oncoReveal™ CDx
MPLN
BRAF V600E/V600K Somatic Mutation Analysis, Tumor
Mayo Clinic Lab
NeoSITE™ Melanoma
NeoGenomics